DZ2538A1 - Tartrate d'un dipeptide substitué procédé pour sa préparation et compositions pharmaceutiques le contenant. - Google Patents

Tartrate d'un dipeptide substitué procédé pour sa préparation et compositions pharmaceutiques le contenant.

Info

Publication number: DZ2538A1
Authority: DZ; Algeria
Prior art keywords: tartrate; preparation; pharmaceutical compositions; compositions containing; substituted dipeptide
Prior art date: 1997-06-25

Application number

DZ980148A

Other languages

English (en)

French (fr)

Inventor

Philip Albert Carpino

Paul Andrew Dasilva-Jardine

Bruce Allen Let Ker

Jerry Anthony Murry

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-25

Filing date

1998-06-24

Publication date

2003-02-08

1998-06-24 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2003-02-08 Application granted granted Critical

2003-02-08 Publication of DZ2538A1 publication Critical patent/DZ2538A1/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Neurology (AREA)
Crystallography & Structural Chemistry (AREA)
Emergency Medicine (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Neurosurgery (AREA)

DZ980148A 1997-06-25 1998-06-24 Tartrate d'un dipeptide substitué procédé pour sa préparation et compositions pharmaceutiques le contenant. DZ2538A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5072397P	1997-06-25	1997-06-25

Publications (1)

Publication Number	Publication Date
DZ2538A1 true DZ2538A1 (fr)	2003-02-08

Family

ID=21966996

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ980148A DZ2538A1 (fr)	1997-06-25	1998-06-24	Tartrate d'un dipeptide substitué procédé pour sa préparation et compositions pharmaceutiques le contenant.

Country Status (40)

Country	Link
US (2)	US6248717B1 (pt)
EP (1)	EP0989993B1 (pt)
JP (1)	JP3414759B2 (pt)
KR (1)	KR100339936B1 (pt)
CN (2)	CN1524857A (pt)
AP (1)	AP1043A (pt)
AR (1)	AR012255A1 (pt)
AT (1)	ATE388163T1 (pt)
AU (1)	AU744775B2 (pt)
BG (1)	BG104024A (pt)
BR (1)	BR9810623B1 (pt)
CA (1)	CA2294422C (pt)
CO (1)	CO4810383A1 (pt)
DE (1)	DE69839211T2 (pt)
DK (1)	DK0989993T3 (pt)
DZ (1)	DZ2538A1 (pt)
EA (1)	EA002643B1 (pt)
ES (1)	ES2301196T3 (pt)
GT (1)	GT199800085A (pt)
HR (1)	HRP980362A2 (pt)
HU (1)	HUP0002664A3 (pt)
ID (1)	ID23188A (pt)
IL (1)	IL132810A0 (pt)
IS (1)	IS5276A (pt)
MA (1)	MA26516A1 (pt)
NO (1)	NO996469L (pt)
NZ (1)	NZ500658A (pt)
OA (1)	OA11241A (pt)
PA (1)	PA8453401A1 (pt)
PE (1)	PE97599A1 (pt)
PL (1)	PL337654A1 (pt)
PT (1)	PT989993E (pt)
SK (1)	SK177299A3 (pt)
TN (1)	TNSN98111A1 (pt)
TR (1)	TR199903261T2 (pt)
TW (1)	TWI221153B (pt)
UA (1)	UA53716C2 (pt)
UY (1)	UY25059A1 (pt)
WO (1)	WO1998058948A1 (pt)
ZA (1)	ZA985541B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HN1996000101A (es) *	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis
UA64751C2 (uk)	1997-06-25	2004-03-15	Пфайзер Продактс Інк.	Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
UA53716C2 (uk)	1997-06-25	2003-02-17	Пфайзер Продактс Інк.	Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
US6465445B1 (en) *	1998-06-11	2002-10-15	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6380184B1 (en)	1998-10-28	2002-04-30	Bristol-Myers Squibb Co.	Benzoazepines and analogs thereof useful as growth hormone secretagogues
KR100699404B1 (ko)	1999-02-18	2007-03-23	가켄 세야쿠 가부시키가이샤	성장 호르몬 분비촉진제로서의 신규 아미드 유도체
US6541634B2 (en)	1999-02-26	2003-04-01	Pfizer Inc.	Process for preparing growth hormone secretagogues
US6525203B1 (en)	1999-03-12	2003-02-25	Bristol-Myers Squibb Company	Heterocyclic aromatic compounds useful as growth hormone secretagogues
US6518292B1 (en)	1999-03-12	2003-02-11	Bristol-Myers Squibb Co.	Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
US20020013327A1 (en) *	2000-04-18	2002-01-31	Lee Andrew G.	Compositions and methods for treating female sexual dysfunction
ES2252230T3 (es)	2000-05-11	2006-05-16	Bristol-Myers Squibb Company	Analogos de tetrahidroisoquinolina utiles como secretores de la hormona del crecimiento.
CA2410597A1 (en)	2000-05-30	2001-12-06	Merck & Co., Inc.	Melanocortin receptor agonists
EP1159964B1 (en) *	2000-05-31	2009-10-28	Pfizer Products Inc.	Use of growth hormone secretagogues for stimulating gastrointestinal motility
IL143690A0 (en) *	2000-06-19	2002-04-21	Pfizer Prod Inc	The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease
EP1181933A3 (en) *	2000-06-29	2002-04-10	Pfizer Products Inc.	Use of growth hormone secretagogues for stimulating or increasing appetite
IL143942A0 (en) *	2000-06-29	2002-04-21	Pfizer Prod Inc	Use of growth hormone secretagogues for treatment of physical performance decline
BR0113626A (pt) *	2000-08-30	2003-06-17	Pfizer Prod Inc	Formulações de liberação sustentada para secretores de hormÈnio do crescimento
IL145106A0 (en) *	2000-08-30	2002-06-30	Pfizer Prod Inc	Intermittent administration of a geowth hormone secretagogue
EP1192943A3 (en) *	2000-09-28	2002-11-27	Pfizer Products Inc.	Use of growth hormone secretagogues in conjunction with physical exercise
CZ20031029A3 (cs) *	2000-10-13	2003-09-17	Eli Lilly And Company	Substituované dipeptidy jako sekretagogy růstového hormonu
CA2372450A1 (en) *	2001-05-10	2001-09-19	Pharmaceutical Partners Of Canada Inc.	Liquid injectable formulation of disodium pamidronate
US7125840B2 (en)	2001-10-09	2006-10-24	Eli Lilly And Company	Substituted dipeptides as growth hormone secretagogues
US6649606B1 (en)	2001-11-09	2003-11-18	Bristol-Myers Squibb Co.	Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
ES2266798T3 (es)	2002-04-09	2007-03-01	Eli Lilly And Company	Secretagodos de hormona de crecimiento.
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
WO2005027913A1 (en) *	2003-09-19	2005-03-31	Pfizer Products Inc.	Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
WO2005097788A2 (en) *	2004-04-02	2005-10-20	Elixir Pharmaceuticals, Inc.	Sulfonamides and uses thereof
KR100641571B1 (ko) *	2005-01-05	2006-10-31	주식회사 팬택앤큐리텔	이동통신 단말기에서의 클럭 발생 장치
CU23558A1 (es)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
AU2008241532A1 (en)	2007-02-09	2008-10-30	Tranzyme Pharma, Inc.	Macrocyclic ghrelin receptor modulators and methods of using the same
US8377863B2 (en)	2007-05-29	2013-02-19	Unigene Laboratories Inc.	Peptide pharmaceutical for oral delivery
US20140213759A1 (en) *	2011-06-16	2014-07-31	Lonza Braine S.A.	Process For Extraction Of Peptides And Its Application In Liquid Phase Peptide Synthesis
EP2780021A4 (en) *	2011-11-16	2015-08-05	Univ Duke	BISPHOSPHONATE COMPOSITIONS AND METHODS FOR TREATING AND / OR REDUCING HEART FAILURE
US9119832B2 (en)	2014-02-05	2015-09-01	The Regents Of The University Of California	Methods of treating mild brain injury
US9833411B2 (en)	2015-01-12	2017-12-05	Enteris Biopharma, Inc.	Solid oral dosage forms
US20170121385A1 (en)	2015-10-28	2017-05-04	Oxeia Biopharmaceuticals, Inc.	Methods of treating neurodegenerative conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4411890A (en)	1981-04-14	1983-10-25	Beckman Instruments, Inc.	Synthetic peptides having pituitary growth hormone releasing activity
WO1994011012A1 (en)	1992-11-06	1994-05-26	Merck & Co., Inc.	Substituted dipeptide analogs promote release of growth hormone
NZ258412A (en)	1992-12-11	1997-01-29	Merck & Co Inc	Spiro-fused piperidine derivatives and pharmaceutical compositions
PL322706A1 (en) *	1993-11-09	1998-02-16	Merck & Co Inc	Piperidines, pyrolidines and hexahydro-1h-azepins enhancing growth hormone liberation
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
UA53716C2 (uk)	1997-06-25	2003-02-17	Пфайзер Продактс Інк.	Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
UA64751C2 (uk)	1997-06-25	2004-03-15	Пфайзер Продактс Інк.	Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
GT199800127A (es)	1997-08-29	2000-02-01		Combinaciones terapeuticas.

1998
- 1998-05-06 UA UA99127067A patent/UA53716C2/uk unknown
- 1998-06-05 DE DE69839211T patent/DE69839211T2/de not_active Expired - Lifetime
- 1998-06-05 PL PL98337654A patent/PL337654A1/xx unknown
- 1998-06-05 CN CNA2004100059410A patent/CN1524857A/zh active Pending
- 1998-06-05 ID IDW991663A patent/ID23188A/id unknown
- 1998-06-05 EP EP98921681A patent/EP0989993B1/en not_active Expired - Lifetime
- 1998-06-05 DK DK98921681T patent/DK0989993T3/da active
- 1998-06-05 AU AU74455/98A patent/AU744775B2/en not_active Ceased
- 1998-06-05 HU HU0002664A patent/HUP0002664A3/hu unknown
- 1998-06-05 WO PCT/IB1998/000874 patent/WO1998058948A1/en active IP Right Grant
- 1998-06-05 ES ES98921681T patent/ES2301196T3/es not_active Expired - Lifetime
- 1998-06-05 PT PT98921681T patent/PT989993E/pt unknown
- 1998-06-05 KR KR1019997012222A patent/KR100339936B1/ko not_active IP Right Cessation
- 1998-06-05 US US09/380,886 patent/US6248717B1/en not_active Expired - Lifetime
- 1998-06-05 AT AT98921681T patent/ATE388163T1/de not_active IP Right Cessation
- 1998-06-05 JP JP50402799A patent/JP3414759B2/ja not_active Expired - Fee Related
- 1998-06-05 EA EA199901076A patent/EA002643B1/ru not_active IP Right Cessation
- 1998-06-05 NZ NZ500658A patent/NZ500658A/en unknown
- 1998-06-05 CN CN98806559A patent/CN1314912A/zh active Pending
- 1998-06-05 CA CA002294422A patent/CA2294422C/en not_active Expired - Lifetime
- 1998-06-05 SK SK1772-99A patent/SK177299A3/sk unknown
- 1998-06-05 TR TR1999/03261T patent/TR199903261T2/xx unknown
- 1998-06-05 BR BRPI9810623-6A patent/BR9810623B1/pt not_active IP Right Cessation
- 1998-06-05 IL IL13281098A patent/IL132810A0/xx unknown
- 1998-06-11 PA PA19988453401A patent/PA8453401A1/es unknown
- 1998-06-18 GT GT199800085A patent/GT199800085A/es unknown
- 1998-06-18 AP APAP/P/1998/001266A patent/AP1043A/en active
- 1998-06-19 PE PE1998000540A patent/PE97599A1/es not_active Application Discontinuation
- 1998-06-22 TW TW087110024A patent/TWI221153B/zh not_active IP Right Cessation
- 1998-06-23 AR ARP980103022A patent/AR012255A1/es not_active Application Discontinuation
- 1998-06-23 UY UY25059A patent/UY25059A1/es not_active IP Right Cessation
- 1998-06-24 TN TNTNSN98111A patent/TNSN98111A1/fr unknown
- 1998-06-24 DZ DZ980148A patent/DZ2538A1/xx active
- 1998-06-24 MA MA25138A patent/MA26516A1/fr unknown
- 1998-06-25 ZA ZA9805541A patent/ZA985541B/xx unknown
- 1998-06-25 HR HR60/050,723A patent/HRP980362A2/hr not_active Application Discontinuation
- 1998-06-25 CO CO98036378A patent/CO4810383A1/es unknown
1999
- 1999-11-26 IS IS5276A patent/IS5276A/is unknown
- 1999-12-16 BG BG104024A patent/BG104024A/bg unknown
- 1999-12-21 OA OA9900299A patent/OA11241A/en unknown
- 1999-12-23 NO NO996469A patent/NO996469L/no not_active Application Discontinuation
2000
- 2000-12-11 US US09/734,269 patent/US6596867B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CN1314912A (zh)	2001-09-26
TNSN98111A1 (fr)	2005-03-15
EA199901076A1 (ru)	2000-08-28
NO996469D0 (no)	1999-12-23
UY25059A1 (es)	2000-12-29
EP0989993B1 (en)	2008-03-05
TR199903261T2 (xx)	2000-08-21
JP3414759B2 (ja)	2003-06-09
DE69839211T2 (de)	2009-03-19
IS5276A (is)	1999-11-26
AP1043A (en)	2002-02-04
PA8453401A1 (es)	2000-05-24
ES2301196T3 (es)	2008-06-16
JP2000514840A (ja)	2000-11-07
US6248717B1 (en)	2001-06-19
MA26516A1 (fr)	2004-12-20
ID23188A (id)	2000-03-23
HUP0002664A3 (en)	2001-12-28
KR20010014153A (ko)	2001-02-26
AU7445598A (en)	1999-01-04
BR9810623A (pt)	2000-07-25
HRP980362A2 (en)	1999-02-28
DK0989993T3 (da)	2008-06-02
CN1524857A (zh)	2004-09-01
PE97599A1 (es)	1999-10-12
PL337654A1 (en)	2000-08-28
BR9810623B1 (pt)	2010-06-15
CA2294422A1 (en)	1998-12-30
EA002643B1 (ru)	2002-08-29
NZ500658A (en)	2001-08-31
US20010016570A1 (en)	2001-08-23
CA2294422C (en)	2003-07-22
BG104024A (bg)	2000-07-31
ZA985541B (en)	2000-01-10
AR012255A1 (es)	2000-09-27
OA11241A (en)	2003-05-26
EP0989993A1 (en)	2000-04-05
TWI221153B (en)	2004-09-21
PT989993E (pt)	2008-04-15
CO4810383A1 (es)	1999-06-30
HUP0002664A2 (hu)	2000-12-28
NO996469L (no)	2000-02-23
UA53716C2 (uk)	2003-02-17
SK177299A3 (en)	2001-09-11
AU744775B2 (en)	2002-03-07
KR100339936B1 (ko)	2002-06-10
GT199800085A (es)	1999-12-10
ATE388163T1 (de)	2008-03-15
IL132810A0 (en)	2001-03-19
US6596867B2 (en)	2003-07-22
AP9801266A0 (en)	1998-06-30
WO1998058948A1 (en)	1998-12-30
DE69839211D1 (de)	2008-04-17

Publication	Publication Date	Title
DZ2538A1 (fr)	2003-02-08	Tartrate d'un dipeptide substitué procédé pour sa préparation et compositions pharmaceutiques le contenant.
DZ2666A1 (fr)	2003-03-22	Dérivés d'acide hydroxamique compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2303A1 (fr)	2002-12-28	Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2581A1 (fr)	2003-02-22	Dérivés d'acides aryloxyarylsulfonylaminohydroxamiques procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2745A1 (fr)	2003-09-08	BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2740136B1 (fr)	1998-01-09	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
DZ2523A1 (fr)	2003-02-01	Formulations pharmaceutiques contenant du voriconazole et procédé pour leur préparation.
DZ2358A1 (fr)	2002-12-28	Amides inhibiteurs de sécrétion de apo b/mtp procédé pour leur préparation et compositions pharmaceutiques les contenant
DZ2300A1 (fr)	2002-12-25	Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr)	2002-12-25	Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2753A1 (fr)	2005-09-15	Hydroxamides d'acides (4-arylsulfonylamino)-tétrahydropyranne-4-carboxyliques) procédé pour leur préparation et compositions les contenant.
DZ2045A1 (fr)	2002-07-21	Amides thérapeutiques, procédé pour leur préparation et compositions les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2773A1 (fr)	2003-12-01	Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2596A1 (fr)	2003-02-22	Associations pharmaceutiques d'amlodipine et d'atorvastatine et procédé pour leur préparation.
DZ2416A1 (fr)	2003-01-04	Dérivés d'acide arylsulfonylhydroxamique procédé pour leur préparation et compositions les contenant.
DZ2550A1 (fr)	2003-02-08	Dérivés d'azétidinylpropylpipéridine procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2758A1 (fr)	2003-09-15	Dérivés bicycliques d0acide hydroxamique nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2407A1 (fr)	2003-01-04	Dérivés de sulfonylurée procédé pour leur préparation et compositions pharmaceutiques les contenant
MA26526A1 (fr)	2004-12-20	Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26430A1 (fr)	2004-12-20	4 (3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2227A1 (fr)	2002-12-25	Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant.
DZ2600A1 (fr)	2003-03-01	Associations pharmaceutiques d'amlodipine et d'unestatine et procédé pour leur préparation.
MA23834A1 (fr)	1996-10-01	Procede de preparation de composes inhibiteurs de l'enzyme lp-pla2 et de compositions pharmaceutiques les contenant
DZ2679A1 (fr)	2003-03-29	Forme hydratée nouvelle d'un dérivé de thiazolidinedione procédé pour sa préparation et composition pharmaceutique la contenant.